Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for prevention of blood loss in high-risk vaginal delivery
NCT04201951Completed
- Sponsor
- Hawler Medical University
- Start
- Feb 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tranexamic acid in postpartum hemorrhage (PPH) (2 arms), sponsored by Hawler Medical University. Primary endpoint: Vaginal blood loss in the third and fourth stages at 2 hours. Started Feb 2020; status: completed.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT04201951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04201951.